Literature DB >> 17571244

[Renal manifestations in rheumatic diseases].

K de Groot1.   

Abstract

Inflammatory rheumatic diseases other than systemic vasculitides and systemic lupus erythematosus are frequently associated with renal abnormalities, which are clinically less apparent due to the subtle course and the often only moderate impairment of renal function. These abnormalities include vascular, glomerular and tubulointerstitial changes. Renal manifestations in the course of rheumatoid arthritis influence the prognosis of the disease. Renal involvement due to AA amyloidosis following long-standing inflammatory joint disease can lead slowly, over years, to end-stage renal disease. A scleroderma renal crisis in the course of systemic sclerosis can potentially result in end-stage renal disease within days. The differential diagnosis of renal abnormalities in a rheumatic patient should include drug induced renal impairment as well as infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571244     DOI: 10.1007/s00108-007-1887-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  The protean face of renal sarcoidosis.

Authors:  Ursula Göbel; Ralph Kettritz; Wolfgang Schneider; Friedrich C Luft
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

2.  Serum renin and renin substrate levels in scleroderma.

Authors:  R Fleischmajer; A B Gould
Journal:  Proc Soc Exp Biol Med       Date:  1975-11

Review 3.  Scleroderma renal crisis.

Authors:  Virginia D Steen
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

4.  Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.

Authors:  Antonio Fernández-Nebro; Eva Tomero; Vera Ortiz-Santamaría; María Carmen Castro; Alejandro Olivé; Manuel de Haro; Rosa García Portales; Rosa García-Vicuña; María Victoria González-Mari; Armando Laffón; Rosario García-Vicuña
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

Review 5.  Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports.

Authors:  E S Strobel; E Fritschka
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 6.  Clinical impact of bone and calcium metabolism changes in sarcoidosis.

Authors:  G Rizzato
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

Review 7.  The clinical spectrum of primary renal vasculitis.

Authors:  Michael Samarkos; Sozos Loizou; George Vaiopoulos; Kevin A Davies
Journal:  Semin Arthritis Rheum       Date:  2005-10       Impact factor: 5.532

8.  Increased frequency of ultrasonographic findings suggestive of renal stones in patients with ankylosing spondylitis.

Authors:  C Korkmaz; A Ozcan; N Akçar
Journal:  Clin Exp Rheumatol       Date:  2005 May-Jun       Impact factor: 4.473

9.  The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.

Authors:  P J Cannon; M Hassar; D B Case; W J Casarella; S C Sommers; E C LeRoy
Journal:  Medicine (Baltimore)       Date:  1974-01       Impact factor: 1.889

10.  Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.

Authors:  J S Adams; O P Sharma; M A Gacad; F R Singer
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.